Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DX9KA5
|
||||
Drug Name |
2-Amino-6,7-dibenzyloxy-1-(4-methoxyphenyl)-2Hisoquinolin-3-one
|
||||
Synonyms |
CHEMBL603639
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C30H26N2O4
|
||||
Canonical SMILES |
COc1ccc(cc1)C2=C3C=C(OCc4ccccc4)C(=CC3=CC(=O)N2N)OCc5ccccc5
|
||||
InChI |
InChI=1S/C30H26N2O4/c1-34-25-14-12-23(13-15-25)30-26-18-28(36-20-22-10-6-3-7-11-22)27(16-24(26)17-29(33)32(30)31)35-19-21-8-4-2-5-9-21/h2-18H,19-20,31H2,1H3
|
||||
InChIKey |
VYDRKZGLXMYJQK-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Cathepsin L | Target Info | [1587926] | ||
Cathepsin B | Target Info | [1587926] | |||
Reactome | Endosomal/Vacuolar pathway | ||||
Collagen degradation | |||||
Degradation of the extracellular matrix | |||||
Trafficking and processing of endosomal TLR | |||||
Assembly of collagen fibrils and other multimeric structures | |||||
MHC class II antigen presentationR-HSA-1442490:Collagen degradation | |||||
MHC class II antigen presentation | |||||
WikiPathways | Primary Focal Segmental Glomerulosclerosis FSGS | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.